A recent study published in JAMA Psychiatry has uncovered promising evidence suggesting that glucagon-like peptide-1 (GLP-1) ...

美银证券的分析师强调了诺和诺德公司最近的行动可能会影响Hims & Hers的战略。上周，诺和诺德公司向FDA提交了一份公民请愿书，寻求限制复合药房生产其糖尿病药物Victoza（通用名为liraglutide）的仿制版。

Researchers from Canada reviewed the results of 26 trials to determine which of the weight loss jabs are the most effective ...

In December, Danish pharmaceutical giant Novo Nordisk A/S (NYSE:NVO) submitted a Citizen Petition to the FDA requesting the ...

PEOPLE TAKING GLP-1S have a reduced risk of heart attacks, strokes, and death from cardiovascular disease, according to a ...

The FDA has approved Liraglutide Injection, the first generic version of Victoza, for the treatment of type 2 diabetes.

These medications were sitagliptin, liraglutide, glimepiride, or insulin glargine U-100. Sitagliptin, liraglutide, and ...

Ke, X. and Ma, T. (2025) Protective Effect of Liraglutide on Early Renal Fibrosis in Diabetes Mice. Journal of Biosciences and Medicines, 13, 84-91. doi: 10.4236/jbm.2025.131008 .

In its Citizen Petition to the FDA, Novo Nordisk argued that there is no clinical need to allow compounding for liraglutide, ...

Lexaria Bioscience (LEXX) it has received the necessary independent ethics board approval required for its contract research organization to ...

Alcohol intake dropped from 23 units to eight per week - roughly the equivalent to going from 12 pints a week to only four.

Obesity medications could help heavy drinkers cut down on the booze as well as helping them lose weight, new research has ...